European Commission Approves Gilead’s Trodelvy For Pre-Treated HR+/HER2- Metastatic Breast Cancer Read more
InSilicoTrials and Axoltis Pharma Collaborate to Advance Therapeutic Solutions for Neurological Disorders Read more
LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis Read more
Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders Read more
ImmunoGen Announces Multi-Target License and Option Agreement with ImmunoBiochem to Develop Next-Generation Antibody-Drug Conjugates Read more
Alnylam Announces Partnership with Roche to Co-Develop and Co-Commercialize Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension in Patients with High Cardiovascular Risk Read more
VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention and Treatment in License and Collaboration Agreements for up to $437 Million Plus Royalties Read more